Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.28.529447Source: DataRank Database

A scalable, GMP-compatible, autologous organotypic cell therapy for Dystrophic Epidermolysis Bullosa is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: greenTopics (30)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (27)

Jessica L. Torkelson ORCID,Shengdi Li ORCID,Kelly McCarthy,Hanson H. Zhen,Madhuri Vangipuram ORCID

Live enrichment

PubMed:36909618 OpenAlex:https://openalex.org/W4323039040

National Institutes of Health

Grant: 5R01GM121932-04

Capturing the phenotypic landscape of single-nucleotide variation via systematic genome editing

NIGMS NIH HHS

Grant: R01 GM121932

greenLicense: cc-by-nc-nd

repositoryhttps://www.biorxiv.org/content/biorxiv/early/2023/03/01/2023.02.28.529447.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1101/2023.02.28.529447

repositoryhttps://doi.org/10.1101/2023.02.28.529447

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36909618

Fields of Study

Skin and Cellular Biology ResearchPluripotent Stem Cells ResearchCRISPR and Genetic Engineering0303 health sciences03 medical and health sciences

Keywords

Induced pluripotent stem cellReprogrammingCell therapyEpidermolysis bullosaCellBiologyGenome editingStem cellCancer researchCRISPRCell biologyEmbryonic stem cellGeneGeneticsArticleCRISPR-CAS9Induced Pluripotent Stem Cells (iPS cells)dermal fibroblastsepitheliumgene editinggood manufacturing practices compatibility (c-GMP)keratinocyteskintissue engineeringwound healing

Sustainable Development Goals

SDG 0: Good health and well-being